Susquehanna Portfolio Strategies
AMRX icon

Susquehanna Portfolio Strategies’s Amneal Pharmaceuticals AMRX Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.97M Sell
113,989
-214,014
-65% -$2.93M 0.03% 439
2026
Q1 		$4.08M Hold
328,003
– – 0.06% 336
2025
Q4 		$4.13M Hold
328,003
– – 0.06% 338
2025
Q3 		$3.28M Buy
328,003
+82,808
+34% +$743K 0.05% 392
2025
Q2 		$1.98M Buy
245,195
+206,674
+537% +$1.56M 0.04% 375
2025
Q1 		$323K Buy
+38,521
New +$322K 0.14% 96
2024
Q2 		– Sell
-64,584
Closed -$391K – 515
2024
Q1 		$391K Sell
64,584
-3,247
-5% -$18.3K 0.01% 627
2023
Q4 		$412K Buy
+67,831
New +$302K 0.01% 802

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TPG GP A
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Rubric Capital Management (New York)
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Susquehanna Portfolio Strategies's AMRX Position: Q2 2026 in Review

Susquehanna Portfolio Strategies reduced its Amneal Pharmaceuticals (AMRX) stake by 65% in Q2 2026, selling an estimated $2.93M and leaving 113,989 shares worth $1.97M. The position accounts for 0.03% of the portfolio, ranked #439.

Susquehanna Portfolio Strategies first reported a position in AMRX in Q4 2023 and has held it in 8 quarters since. The position peaked at $4.13M in Q4 2025. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Susquehanna Portfolio Strategies held 113,989 shares of Amneal Pharmaceuticals worth $1.97M as of Q2 2026.
  • Susquehanna Portfolio Strategies sold 214,014 Amneal Pharmaceuticals shares in Q2 2026, an estimated $2.93M.
  • Amneal Pharmaceuticals made up 0.03% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #439 holding.
  • Susquehanna Portfolio Strategies first reported a position in Amneal Pharmaceuticals in Q4 2023 and has held it in 8 quarters since.
  • Susquehanna Portfolio Strategies's Amneal Pharmaceuticals position peaked at $4.13M in Q4 2025.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.